François Ducray

12.0k total citations · 3 hit papers
206 papers, 6.3k citations indexed

About

François Ducray is a scholar working on Genetics, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, François Ducray has authored 206 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 146 papers in Genetics, 73 papers in Neurology and 53 papers in Pulmonary and Respiratory Medicine. Recurrent topics in François Ducray's work include Glioma Diagnosis and Treatment (144 papers), Brain Metastases and Treatment (40 papers) and Meningioma and schwannoma management (38 papers). François Ducray is often cited by papers focused on Glioma Diagnosis and Treatment (144 papers), Brain Metastases and Treatment (40 papers) and Meningioma and schwannoma management (38 papers). François Ducray collaborates with scholars based in France, Italy and United States. François Ducray's co-authors include Jean‐Yves Delattre, Ahmed Idbaïh, Khê Hoang‐Xuan, Jérôme Honnorat, Karima Mokhtari, Damien Ricard, Marc Sanson, M. Lahutte, Véronique Rogemond and Yannick Marie and has published in prestigious journals such as The Lancet, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

François Ducray

193 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas

2009 773 citations Marc Sanson, Yannick Marie et al. Journal of Clinical Oncology profile →
Primary brain tumours in adults

2012 730 citations Damien Ricard, Ahmed Idbaïh et al. profile →
Repeated blood–brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I/II clinical trial

2024 54 citations Olivier Chinot, François Ducray et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
François Ducray France	38	3.5k	2.1k	1.7k	1.3k	1.2k	206	6.3k
Pascale Varlet France	44	3.9k 1.1×	1.8k 0.8×	1.9k 1.1×	1.1k 0.8×	783 0.6×	233	6.6k
Roland Goldbrunner Germany	38	2.6k 0.8×	1.6k 0.8×	1.9k 1.1×	1.2k 1.0×	1.0k 0.8×	242	7.4k
Gino Cioffi United States	19	4.1k 1.2×	1.3k 0.6×	2.0k 1.2×	1.5k 1.2×	1.3k 1.0×	70	7.4k
Gelareh Zadeh Canada	47	2.8k 0.8×	1.5k 0.7×	2.2k 1.3×	1.4k 1.1×	1.4k 1.1×	328	7.9k
Felix Sahm Germany	47	3.8k 1.1×	1.6k 0.8×	2.5k 1.5×	1.2k 0.9×	1.4k 1.1×	250	8.8k
Ulrich Herrlinger Germany	50	5.1k 1.5×	2.8k 1.3×	2.2k 1.3×	1.9k 1.5×	824 0.7×	269	9.0k
Felice Giangaspero Italy	55	4.9k 1.4×	2.4k 1.2×	4.0k 2.3×	1.7k 1.3×	1.4k 1.2×	301	9.7k
Patrick Roth Switzerland	44	3.2k 0.9×	1.3k 0.6×	2.0k 1.1×	1.1k 0.8×	1.1k 0.9×	202	7.2k
Sridharan Gururangan United States	42	4.4k 1.3×	1.4k 0.7×	2.4k 1.4×	1.8k 1.4×	1.5k 1.2×	118	6.8k
Elizabeth R. Gerstner United States	41	3.0k 0.9×	1.2k 0.6×	1.3k 0.8×	1.0k 0.8×	976 0.8×	147	5.9k

Countries citing papers authored by François Ducray

Since Specialization

Citations

This map shows the geographic impact of François Ducray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Ducray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Ducray more than expected).

Fields of papers citing papers by François Ducray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Ducray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Ducray. The network helps show where François Ducray may publish in the future.

Co-authorship network of co-authors of François Ducray

This figure shows the co-authorship network connecting the top 25 collaborators of François Ducray. A scholar is included among the top collaborators of François Ducray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Ducray. François Ducray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Manet, Romain, et al.. (2025). Predominantly cystic craniopharyngiomas: Current management approaches, outcomes and limitations. Best Practice & Research Clinical Endocrinology & Metabolism. 39(5). 101981–101981. 1 indexed citations

Guyotat, Jacques, I. Pélissou-Guyotat, Timothée Jacquesson, et al.. (2024). Predictors of Progression in a Series of 81 Adult Patients Surgically Managed for an Intracranial Hemangioblastoma: Implications for the Postoperative Follow-Up. Cancers. 16(7). 1261–1261. 2 indexed citations

Vidal, Chrystelle, Olivier Chinot, E. Cohen-Jonathan Moyal, et al.. (2022). Characteristics of Anaplastic Oligodendrogliomas Short-Term Survivors: A POLA Network Study. The Oncologist. 27(5). 414–423. 4 indexed citations

Picart, Thiébaud, Chloé Dumot, David Meyronet, et al.. (2021). Characteristics and management of hydrocephalus in adult patients with cerebellar glioblastoma: lessons from a French nationwide series of 118 cases. Neurosurgical Review. 45(1). 683–699. 6 indexed citations

Jacques, Audrey, et al.. (2021). Primary intracranial germinoma mimicking meningioma in an elderly patient. Revue Neurologique. 177(8). 1020–1022.

Picart, Thiébaud, David Meyronet, Johan Pallud, et al.. (2021). Management, functional outcomes and survival in a French multicentric series of 118 adult patients with cerebellar glioblastoma. Journal of Cancer Research and Clinical Oncology. 147(6). 1843–1856. 5 indexed citations

Picart, Thiébaud, Marc Barritault, Delphine Poncet, et al.. (2021). Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults. Neuro-Oncology Advances. 3(1). vdab061–vdab061. 47 indexed citations

Joubert, Bastien, Julie Haesebaert, Sylvain Rheims, et al.. (2020). Long-term outcomes in temporal lobe epilepsy with glutamate decarboxylase antibodies. Journal of Neurology. 267(7). 2083–2089. 30 indexed citations

Vogrig, Alberto, Sergio Muñiz‐Castrillo, Bastien Joubert, et al.. (2020). Cranial Nerve Disorders Associated With Immune Checkpoint Inhibitors. Neurology. 96(6). e866–e875. 44 indexed citations

10.

Simard, Claire, Alberto Vogrig, Bastien Joubert, et al.. (2020). Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies. Neurology Neuroimmunology & Neuroinflammation. 7(3). 58 indexed citations

11.

Laigle–Donadey, Florence, François Ducray, Matthieu Boone, et al.. (2019). A phase III double-blind placebo-controlled randomized study of dexamphetamine sulfate for fatigue in primary brain tumors patients: An ANOCEF trial (DXA). Neuro-Oncology Advances. 1(1). vdz043–vdz043. 8 indexed citations

12.

Berzero, Giulia, Thierry Maisonobe, François Salachas, et al.. (2018). Motor neuron disease of paraneoplastic origin: a rare but treatable condition. Journal of Neurology. 265(7). 1590–1599. 25 indexed citations

13.

Joubert, Bastien, Florent Gobert, Laure Thomas, et al.. (2017). Autoimmune episodic ataxia in patients with anti-CASPR2 antibody-associated encephalitis. Neurology Neuroimmunology & Neuroinflammation. 4(4). e371–e371. 56 indexed citations

14.

Moutal, Aubin, Jérôme Honnorat, Chantal Watrin, et al.. (2015). CRMP5 Controls Glioblastoma Cell Proliferation and Survival through Notch-Dependent Signaling. Cancer Research. 75(17). 3519–3528. 37 indexed citations

15.

Ducray, François, Geneviève Demarquay, Francesc Graus, et al.. (2014). Seronegative paraneoplastic cerebellar degeneration: the PNS E uronetwork experience. European Journal of Neurology. 21(5). 731–735. 37 indexed citations

16.

Ribba, Benjamin, Gentian Kaloshi, Matthieu Peyre, et al.. (2012). A Tumor Growth Inhibition Model for Low-Grade Glioma Treated with Chemotherapy or Radiotherapy. Clinical Cancer Research. 18(18). 5071–5080. 99 indexed citations

17.

Pallud, Johan, Luc Taillandier, Laurent Capelle, et al.. (2012). Quantitative Morphological Magnetic Resonance Imaging Follow-up of Low-Grade Glioma. Neurosurgery. 71(3). 729–740. 84 indexed citations

18.

Pérez‐Larraya, Jaime Gállego, François Ducray, Olivier Chinot, et al.. (2011). Temozolomide in Elderly Patients With Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial. Journal of Clinical Oncology. 29(22). 3050–3055. 160 indexed citations

19.

Sanson, Marc, Yannick Marie, Sophie Paris, et al.. (2009). Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas. Journal of Clinical Oncology. 27(25). 4150–4154. 773 indexed citations breakdown →

20.

Clarke, Ian D., Peter B. Dirks, Nicole Assard, et al.. (2006). IQGAP1 Protein Specifies Amplifying Cancer Cells in Glioblastoma Multiforme. Cancer Research. 66(18). 9074–9082. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact